Skip to main content
. Author manuscript; available in PMC: 2010 Nov 3.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2009 Nov 3;18(11):2807–2813. doi: 10.1158/1055-9965.EPI-09-0472

Table 2.

Entry characteristics of men subsequently diagnosed with prostate cancer and men found to be free of prostate cancer, placebo arm of the Prostate Cancer Prevention Trial

Subsequent prostate cancer diagnosis

No Yes P
N 4,335 1,251
Mean age (years) 62.6 63.6 < 0.0001
Nonwhite (%) 6.5 7.0 0.52
Mean body mass index (kg/m2) 27.4 27.2 0.11
Mean weight (lb) 192.0 190.9 0.27
Mean height (in) 69.8 67.0 0.07
Mean waist circumference (cm) 100.2 100.0 0.65
Education (%)
  < High school 1.1 1.4 0.29
  High school 16.8 15.0 0.12
  ≥ High school 82.1 83.5 0.26
Cigarette smoking (%)
  Never 33.9 36.7 0.07
  Former 59.4 56.4 0.06
  Current 6.7 6.9 0.80
Physical activity (%)
  Sedentary 16.7 16.9 0.87
  Light 42.1 40.6 0.34
  Moderate 30.8 33.5 0.07
  Active 10.0 8.8 0.21
Family history of prostate cancer (%) 15.7 21.2 < 0.0001
Mean PSA (ng/mL) 1.2 1.5 < 0.0001
History of diabetes (%) 5.2 4.1 0.10
History of heart attack (%) 4.1 4.4 0.65
Regular aspirin use (%) 49.0 53.5 0.005
Vasectomy (%) 34.0 33.8 0.90
Alcohol intake (g/day) 9.7 9.9 0.77
Red meat intake (servings/day) 0.61 0.60 0.31
Energy-adjusted cholesterol intake (mg/day) 281 281 0.91
Calcium intake, diet and supplements (mg/day) 922 939 0.23
*

All characteristics (except for age) are age-adjusted and were calculated as least squares means from linear regression models.

HHS Vulnerability Disclosure